Unichem Laboratories Limited
NSE:UNICHEMLAB.NS
899.65 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 17,048.947 | 13,430.222 | 12,479.82 | 11,899.183 | 11,564.925 | 11,227.701 | 7,781.346 | 15,195.041 | 13,345.638 | 12,017.934 | 11,334.479 | 10,808.028 | 8,754.63 | 8,240.381 | 7,473.86 | 7,352.336 | 6,713.49 | 6,279.39 | 5,472.62 |
| Cost of Revenue
| 11,709.23 | 5,509.267 | 4,405.414 | 4,013.704 | 4,093.952 | 4,672.58 | 3,716.26 | 5,287.314 | 4,696.148 | 4,492.037 | 3,949.497 | 3,949.493 | 3,562.77 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 5,339.717 | 7,920.955 | 8,074.406 | 7,885.479 | 7,470.973 | 6,555.121 | 4,065.086 | 9,907.727 | 8,649.49 | 7,525.897 | 7,384.982 | 6,858.535 | 5,191.86 | 8,240.381 | 7,473.86 | 7,352.336 | 6,713.49 | 6,279.39 | 5,472.62 |
| Gross Profit Ratio
| 0.313 | 0.59 | 0.647 | 0.663 | 0.646 | 0.584 | 0.522 | 0.652 | 0.648 | 0.626 | 0.652 | 0.635 | 0.593 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 1,046.67 | 263.939 | 337.564 | 439.02 | 1,564.075 | 1,163.588 | 849.686 | 616.938 | 438.677 | 464.214 | 521.51 | 364.932 | 392.737 | 383.512 | 291.178 | 272.13 | 321.5 | 0 | 0 |
| General & Administrative Expenses
| 4,265.245 | 333.221 | 324.774 | 364.232 | 493.353 | 341.094 | 236.422 | 304.981 | 295.782 | 2,255.853 | 209.012 | 0.941 | 979.074 | 6,356.099 | 5,474.153 | 5,658.312 | 5,528.41 | 5,352.35 | 4,585.99 |
| Selling & Marketing Expenses
| 157.728 | 1,295.568 | 1,206.776 | 1,225.22 | 2,230.243 | 1,972.422 | 1,116.395 | 2,123.538 | 1,684.518 | 748.386 | 1,340.32 | 1,359.261 | 1,160.018 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4,422.973 | 1,628.789 | 1,531.55 | 1,589.452 | 2,723.596 | 2,313.516 | 1,352.817 | 2,428.519 | 1,980.3 | 3,004.239 | 4,379.544 | 4,024.615 | 2,139.092 | 6,356.099 | 5,474.153 | 5,658.312 | 5,528.41 | 5,352.35 | 4,585.99 |
| Other Expenses
| -1,256.225 | 385.151 | 5.147 | 50.638 | 7.22 | 26.157 | 15.853 | 70.426 | 62.986 | 68.554 | 72.371 | 53.734 | 74.355 | 223.562 | 165.764 | 129.372 | -53.47 | -12.56 | 133.87 |
| Operating Expenses
| 6,725.868 | 9,812.214 | 8,183.416 | 7,812.724 | 8,776.865 | 7,916.743 | 5,887.837 | 8,565.127 | 7,367.787 | 6,925.174 | 6,064 | 5,422.677 | 4,312.746 | 6,963.173 | 5,931.095 | 6,059.814 | 5,964.35 | 5,386.26 | 4,672.13 |
| Operating Income
| -1,386.151 | -1,506.108 | -111.353 | 72.755 | -1,305.892 | -1,361.622 | -1,822.751 | 1,342.6 | 1,281.703 | 600.723 | 1,320.982 | 1,435.858 | 879.114 | 1,277.208 | 1,542.765 | 1,292.522 | 749.14 | 893.13 | 800.49 |
| Operating Income Ratio
| -0.081 | -0.112 | -0.009 | 0.006 | -0.113 | -0.121 | -0.234 | 0.088 | 0.096 | 0.05 | 0.117 | 0.133 | 0.1 | 0.155 | 0.206 | 0.176 | 0.112 | 0.142 | 0.146 |
| Total Other Income Expenses Net
| 769.49 | -257.521 | 331.042 | 442.039 | 823.79 | 762.569 | 525.196 | 69.946 | 95.071 | 173.41 | 390.675 | 24.87 | 61.183 | -9.349 | -10.415 | -18.97 | -67.81 | -24.79 | 117.54 |
| Income Before Tax
| -616.661 | -1,763.629 | 219.689 | 514.794 | -482.102 | -599.053 | -1,297.555 | 1,412.546 | 1,376.774 | 774.133 | 1,711.657 | 1,460.728 | 940.297 | 1,267.859 | 1,532.35 | 1,273.552 | 681.33 | 868.34 | 918.03 |
| Income Before Tax Ratio
| -0.036 | -0.131 | 0.018 | 0.043 | -0.042 | -0.053 | -0.167 | 0.093 | 0.103 | 0.064 | 0.151 | 0.135 | 0.107 | 0.154 | 0.205 | 0.173 | 0.101 | 0.138 | 0.168 |
| Income Tax Expense
| 88.082 | 258.647 | -110.928 | 171.546 | 119.723 | -343.477 | 33.422 | 325.795 | 292.738 | 21.322 | 430.037 | 328.47 | -227.722 | 315.9 | 304.3 | 192 | 172.5 | 165.85 | 115 |
| Net Income
| -704.743 | -2,022.276 | 330.617 | 343.248 | -601.825 | -238.004 | 25,449.103 | 1,086.751 | 1,080.341 | 753.901 | 1,693.075 | 1,132.258 | 712.575 | 951.959 | 1,228.05 | 1,081.552 | 508.83 | 702.49 | 803.03 |
| Net Income Ratio
| -0.041 | -0.151 | 0.026 | 0.029 | -0.052 | -0.021 | 3.271 | 0.072 | 0.081 | 0.063 | 0.149 | 0.105 | 0.081 | 0.116 | 0.164 | 0.147 | 0.076 | 0.112 | 0.147 |
| EPS
| -10.01 | -28.73 | 4.7 | 4.88 | -8.55 | -3.38 | 280.59 | 11.96 | 11.9 | 8.31 | 18.69 | 12.52 | 7.89 | 10.53 | 13.66 | 11.99 | 5.7 | 7.79 | 9.04 |
| EPS Diluted
| -10.01 | -28.73 | 4.68 | 4.88 | -8.55 | -3.38 | 280.41 | 11.96 | 11.88 | 8.29 | 18.63 | 12.48 | 7.86 | 10.47 | 13.58 | 11.98 | 5.7 | 7.79 | 9.02 |
| EBITDA
| -253.746 | -371.671 | 1,225.702 | 1,292.478 | 151.791 | 21.525 | -831.528 | 1,885.302 | 1,830.255 | 1,205.171 | 1,582.698 | 1,819.256 | 1,285.466 | 1,569.387 | 1,774.901 | 1,516.654 | 930.56 | 1,033.11 | 926.99 |
| EBITDA Ratio
| -0.015 | -0.028 | 0.098 | 0.109 | 0.013 | 0.002 | -0.107 | 0.124 | 0.137 | 0.1 | 0.14 | 0.168 | 0.147 | 0.19 | 0.237 | 0.206 | 0.139 | 0.165 | 0.169 |